GSK seeks appeal of recent Daubert ruling in Zantac litigation in Delaware Superior Court. Scientific consensus disputes claim of increased cancer risk...
GSK secures FDA approval for Arexvy in adults aged 50-59 at increased risk for RSV-LRTD. Clinical development ongoing, expanding vaccine benefits globally...
GSK plc celebrates favorable jury verdict in first Zantac trial, highlighting scientific consensus on ranitidine safety and ongoing defense against claims...
GSK PLC's Q1 2024 results show impressive growth in sales, profits, and earnings. CEO Emma Walmsley highlights strong performance and future growth prospects...
GSK plc released promising data on Shingrix vaccine showing high protection against shingles for over a decade in adults over 50. Key findings and implications are detailed in this report...
GSK's MenABCWY vaccine candidate aims to simplify immunization against invasive meningococcal disease. Learn more about this promising development here...
GSK plc announces positive results from DREAMM-8 trial evaluating Blenrep in combination with PomDex for multiple myeloma treatment. Exciting news for patients and potential treatment advancements...
GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development...
GSK seeks appeal of recent Daubert ruling in Zantac litigation in Delaware Superior Court. Scientific consensus disputes claim of increased cancer risk...
GSK secures FDA approval for Arexvy in adults aged 50-59 at increased risk for RSV-LRTD. Clinical development ongoing, expanding vaccine benefits globally...
GSK plc celebrates favorable jury verdict in first Zantac trial, highlighting scientific consensus on ranitidine safety and ongoing defense against claims...
GSK PLC's Q1 2024 results show impressive growth in sales, profits, and earnings. CEO Emma Walmsley highlights strong performance and future growth prospects...
GSK plc released promising data on Shingrix vaccine showing high protection against shingles for over a decade in adults over 50. Key findings and implications are detailed in this report...
GSK's MenABCWY vaccine candidate aims to simplify immunization against invasive meningococcal disease. Learn more about this promising development here...
GSK plc announces positive results from DREAMM-8 trial evaluating Blenrep in combination with PomDex for multiple myeloma treatment. Exciting news for patients and potential treatment advancements...
GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development...
